See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505512_2018_Regulus_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001505512, Regulus Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 66,736,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 775,000 |
| 2 | PropertyPlantAndEquipmentNet | 9,708,000 |
| 3 | remainder_Assets | 590,000 |
| 4 | LiabilitiesCurrent | 32,600,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 9,993,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,837,082 |
| 9 | ResearchAndDevelopmentExpense | 40,504,689 |
| 10 | remainder_Expenses | 9,217,592 |
| 11 | remainder_Revenues | 1,193,612 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -2,110 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 77,809,000 |
| 1 | Liabilities | 42,593,000 |
| 2 | Expenses | 65,559,363 |
| 3 | Revenues | 1,193,612 |
| 4 | StockholdersEquity | 35,216,000 |
| 5 | NetIncome | -64,365,751 |
| 6 | ComprehensiveNetIncome | -64,366,806 |
| 7 | BaseVar | 93,578,542 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.206 |
| 9 | EconomicCapitalRatio | 1.61 |
Edgar->Model Mapping
Feature Distribution
Change over Time
